The latest closing stock price for Adaptimmune Therapeutics as of September 18, 2024 is 1.04.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-935 today, roughly -1 times their original investment - a -26.19% compound annual growth rate over 9 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 2.05, which is 97.1% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.42, which is 59.6% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 1.00.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-935 today, roughly -1 times their original investment - a -26.19% compound annual growth rate over 9 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 2.05, which is 97.1% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.42, which is 59.6% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 1.00.